48 results
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
9 May 24
Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
4:17pm
mission to become a sustainable and growing oncology company improving outcomes for cancer patients.”
FIRST QUARTER 2024 FINANCIAL RESULTS
Net
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
13 Mar 24
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
4:16pm
demonstrated significant progress in transforming the Company’s business model and product portfolio for long-term sustainable growth,” said Denny
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
4 Mar 24
Completion of Acquisition or Disposition of Assets
6:22am
, reduce interest costs, reduce headcount and overhead costs, thereby significantly advancing our efforts to become a sustainable and growing oncology
8-K
EX-99.1
hp0tas4
5 Feb 24
Coherus Amends Term Loan Agreement with Pharmakon Advisors, LP
8:09am
8-K
EX-99.1
ueggsqnxrm537r
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am